Cetera Investment Advisers’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $754K | Buy |
7,220
+65
| +0.9% | +$6.79K | ﹤0.01% | 2636 |
|
2025
Q1 | $834K | Buy |
7,155
+46
| +0.6% | +$5.37K | ﹤0.01% | 2410 |
|
2024
Q4 | $601K | Buy |
7,109
+1,160
| +19% | +$98.1K | ﹤0.01% | 2539 |
|
2024
Q3 | $535K | Sell |
5,949
-183
| -3% | -$16.4K | ﹤0.01% | 2602 |
|
2024
Q2 | $494K | Buy |
6,132
+457
| +8% | +$36.8K | ﹤0.01% | 2607 |
|
2024
Q1 | $453K | Buy |
+5,675
| New | +$453K | ﹤0.01% | 2675 |
|